Articles tagged with Gastrointestinal Disorders
Scientists have identified a key receptor in the digestive tract that triggers pain and inflammation in the colon. By blocking this receptor from entering cells, researchers found significant reduction in pain and inflammation. This discovery holds promise for treating inflammatory bowel disease.
Researchers at MIT have developed a pill that can deliver RNA to the stomach, potentially making vaccines easier to tolerate and treat gastrointestinal diseases. The capsule is designed to release RNA in the stomach, where it can stimulate an immune response without being degraded by digestive enzymes.
A study analyzing US SEER data from 2000-2016 found that younger age groups experienced the steepest increase in distant-stage early-onset colorectal adenocarcinoma incidence. Younger non-Hispanic Black and Hispanic populations showed greater proportions of distant-stage disease.
Researchers at Boston Children's Hospital have developed an organoid platform that identifies drugs that enhance enteroendocrine cell action, potentially reversing diabetes, obesity and gastrointestinal conditions. The system identified three chemicals that drive the formation of EE cells and hormone production.
Proton pump inhibitors are underutilized in high-risk patients due to knowledge gaps and barriers among specialties. Multi-component interventions can improve guideline-based use to prevent upper gastrointestinal bleeding.
A recent study has investigated the effect of donor selection on transplanted microbiota establishment and long-term stability in aged hosts. Autologous FMT demonstrated better resilience than heterologous FMT in restoring gut microbiota diversity after antibiotic-induced perturbation.
Barrett's esophagus is caused by long-term GERD, which leads to changes in cells where the stomach and esophagus meet. Researchers found that stomach cells adopting intestinal cell qualities may be a key factor in its development.
Researchers found that adding tomato concentrate to a mouse's diet reduced intestinal and systemic inflammation in individuals with chronic HIV. The study suggests targeting the inflamed intestine may be a novel way to prevent persistent inflammation.
A study by Kennedy Krieger Institute explores how GI problems in children with autism affect their families. Researchers identified four main themes: anxiety, diet, microbiome imbalance, and medication impact. The findings highlight the need for interventions to address poor gut health and its consequences.
Researchers discovered that people with inflammatory bowel disease (IBD) have higher levels of microplastics in their feces compared to healthy individuals. The study suggests a possible link between microplastic exposure and IBD, but the exact relationship remains unclear.
A study of 685 Italian children found that certain factors, such as age and comorbidities, are associated with severe gastrointestinal symptoms. The research identified key risk factors for severe GI symptoms in this population, shedding light on the complex interactions between SARS-CoV-2 infection and the immune system.
The KEYNOTE-811 trial demonstrates a significant improvement in objective response rate (74.4%) and tumor size reduction compared to trastuzumab and chemotherapy. The combination of pembrolizumab, trastuzumab, and chemotherapy markedly reduces tumor size and induces complete responses in some patients.
Researchers developed an AI system to detect inflammation in ulcerative colitis patients using live colonoscopy videos. The system accurately predicted remission cases with high accuracy, reducing the need for invasive biopsies.
The coating protects bacteria during the freeze-drying and manufacturing process, allowing them to be used therapeutically. The researchers tested the coating on a strain of E. coli and another species that aids in digestion of plant starches.
A study found that specific DNA changes influence bowel habits and predisposition to IBS. Genetic profiles were correlated with questionnaire data, identifying regions of the genome involved in gut motility. This discovery may lead to new drug targets for treating constipation, diarrhoea, and dysmotility syndromes.
A new study links the composition of gut microbiome before infection to HIV susceptibility and progression. Men who contracted HIV in the early days of the pandemic had a greater relative abundance of pro-inflammatory vs. anti-inflammatory gut microbes, which contributed to their increased risk of developing AIDS.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
A study by Tokyo University of Science researchers identifies a novel regulatory axis targeting dendritic cell activity, suppressing autoimmune disease symptoms and bone loss. They discovered DCIR binds to glycoproteins on macrophages and osteoclasts, reducing inflammation and immune responses.
Researchers at Massachusetts General Hospital have uncovered important details about Shigella's translocon, a pore that injects bacterial proteins into infected cells. The findings may help develop an effective strategy to block this critical component of infection and prevent diseases like dysentery.
An international research team discovered that intestinal bacteria can distribute their metabolic products throughout the body via the bloodstream using membrane vesicles. The study found that these vesicles can overcome the blood-brain barrier and enter brain cells, suggesting a new method for delivering drugs or vaccines.
The American Gastroenterological Association (AGA) has released new clinical guidelines that recommend against extensive preprocedural testing to estimate clotting in patients with cirrhosis. This change aims to reduce the risk of morbidity and mortality associated with unnecessary blood clotting tests.
A woman-owned spinout company, Chosen Diagnostics Inc, has received a $2.1M NIH grant to develop and commercialize a noninvasive diagnostic biomarker test for necrotizing enterocolitis. The test, called NECDetect, identifies 93% true positives and 95% true negatives in diagnosing the disease.
A survey of over 50,000 people found that around 11% experience abdominal pain when eating, with symptoms also affecting mental health and daily life. The study highlights the need for meal-related symptoms to be considered in diagnosis and treatment of functional gastrointestinal disorders.
A new surgical procedure called Kareem's procedure has been introduced to treat congenital intestinal malrotation, a condition where the intestines twist, causing serious complications. The study shows favorable outcomes in patients with intact gut and disabling symptoms, with significant improvement in digestive symptoms after surgery.
A comprehensive review reveals how excessive fructose intake can disrupt metabolic pathways, leading to diseases such as diabetes, fatty liver disease, and heart disease. The study highlights the role of protein transporters, gluconeogenesis, and gene-level changes in regulating fructose metabolism.
A study by Kazan Federal University found that probiotics administered to antibiotic-treated mice improved behavior, reduced oxidative stress, and restored gut microbiota diversity. The researchers demonstrated a strong link between the gut microbiota and brain functioning, with potential therapeutic benefits for treating dysbiosis-rel...
Researchers found that hematopoietic cell transplantation (HCT) normalizes the gut microbiota of patients with IBD associated with XIAP deficiency. The study revealed that HCT decreases gut inflammation and restores diversity in gut microbiota, improving symptoms and quality of life for affected individuals.
A study from the University of South Carolina's Environmental Health & Disease Laboratory found that andrographolide successfully restored bacteriomes and viromes, increasing beneficial bacteria and decreasing harmful bacteria. The treatment also decreased gut inflammation and neuroinflammation in veterans with Gulf War Illness.
A new study from the University of Sheffield reveals that vitamin D supplements do not reduce the severity of IBS symptoms or improve quality of life. Despite correcting deficiencies in those with poor vitamin D status, high-dose vitamin D supplementation did not alleviate symptoms.
A review article summarizing IBS research in China aims to bridge the gap in global literature and improve management of the disorder. The study reveals high prevalence rates, recognized risk factors, and effective treatments, including probiotics and traditional Chinese medicine.
A new laboratory method called TaqMan Array Card (TAC) has been validated for detecting a diverse range of bacteria that cause diarrheal disease. The TAC is faster and cheaper than traditional methods while delivering comparable results, enabling comprehensive monitoring of enteropathogens in informal settlements.
A new stem cell therapy strategy has shown promising results in treating intestinal bowel disease in premature infants. The treatment uses human placental-derived stem cells to repair damage caused by the disease and promote healing of the intestinal barrier.
The International Journal of Gastroenterology and Hepatology Diseases is a new subscription-based journal publishing articles on global significance gastrointestinal and liver diseases. It aims to publish experimental and theoretical results in detail, covering advancements in management and diagnosis of diseases.
A link between depression and stomach ulcers has been confirmed in the world's largest study of genetic factors in peptic ulcer disease, involving nearly half a million people. Genetic variations associated with an increased risk of peptic ulcer disease have also been identified.
Researchers have discovered a molecular switch that regulates inflammation in the stomach, triggered by H. Pylori bacteria. The 'switch' uses a previously unknown mechanism to control the infection, allowing it to evade the immune system and cause stomach diseases such as ulcers and cancer.
Researchers at Flinders University have unraveled the neural circuits of the enteric nervous system, revealing how food is slowly mixed and propelled along the digestive tube. This understanding could lead to more effective treatments for conditions like constipation, diarrhea, and pain.
Research found symptomatic GERD a risk factor for TMD, with longer GERD history linked to higher TMD risk. Multidisciplinary management programs may help patients with co-occurring conditions.
A new breath test could diagnose gastrointestinal damage in children without invasive procedures, reducing trauma and costs associated with oesophageal testing. The trial uses a Dipeptidyl peptidase-4 (DPP4) enzyme found in the small intestine to measure gut health.
A new study from the University of Kent has found that a common gut parasite, Blastocystis, can survive under conditions with increased oxygen levels, contrary to previous thinking. This discovery could provide insights into its role in intestinal diseases such as irritable bowel syndrome.
A new study introduces a 17-item questionnaire to identify gastrointestinal disorders in children with autism, which can lead to behavioral problems. The screening tool correctly identified over 80% of children with GI disorders, offering hope for more effective treatment.
Researchers at the University at Buffalo discovered barley as an ideal and safe contrast agent for diagnosing swallowing disorders. The grain's roasted version can illuminate the throat and gastrointestinal tract when struck by a laser beam, providing nuanced and real-time views inside the body.
Researchers at the University of Colorado Anschutz Medical Campus have shed light on intestinal failure-associated liver disease, a condition that affects people relying on IV nutrition due to intestinal damage. The study suggests three possible new targets for drug intervention to prevent or treat the disease.
Researchers at the University of Missouri-Columbia found that diet is not a contributing factor to gastrointestinal issues in children with autism spectrum disorder. Stress, rather than nutrition, appears to be a major contributor to these symptoms.
Researchers found that intestinal fungi exacerbate liver disease and can be protected against by antifungal treatment. Fungi overgrowth leads to inflammation, which kills liver cells and promotes disease progression.
A study from Lund University found that intestinal bacteria can accelerate the development of Alzheimer's disease in mice. The researchers discovered a direct causal link between gut bacteria and the disease, suggesting that modulating the gut microbiota through diet and probiotics could prevent or delay its onset.
Researchers discovered a Polycomb mechanism governing intestinal homeostasis, which is disrupted in coeliac disease and possibly in colorectal cancer. This study sheds light on the pathogenesis of intestinal damage in coeliac disease and provides diagnostic markers.
Researchers used live zebrafish and 3D microscopy to track interactions between gut bacteria, finding that mechanical contractions play a vital role in shaping communities of intestinal microbiota. This discovery offers new insights into the problems experienced by humans with Hirschsprung's disease.
A study found a distinct brain-to-gut pathway where psychological symptoms begin first, while another pathway links gut symptoms to mental health. Higher anxiety and depression levels predicted IBS development within a year.
A team of UNC School of Medicine researchers played a critical role in amending diagnostic criteria questionnaires for functional GI disorders. The Rome IV publication updates the diagnostic tools available to clinicians, incorporating research on symptoms and patient experiences. These changes improve treatment options for millions of...
A study by Children's Hospital Los Angeles found that common pediatric diseases impact the healthy intestinal microbiome, reducing bacterial diversity. The study suggests that prolonged antibiotic treatment and disease process are responsible for changes in intestinal flora.
A retrospective analysis suggests that regular laxative use can stabilize Parkinson's disease rigidity, pointing to potential modifications in underlying disease processes. Further research is planned to confirm the mechanisms involved.
Researchers identified uropathogenic E. coli as the E. coli type most strongly linked to pre-term infant mortality from necrotizing enterocolitis. The study suggests that early identification of this bacteria could help physicians make informed care decisions for vulnerable infants.
Researchers discovered a microbial biomarker that distinguishes premature infants at risk of necrotizing enterocolitis (NEC) from those who don't. Infants with NEC had higher Gammaproteobacteria and lower anaerobic bacteria in their guts compared to controls.
Researchers at the University of Zurich have discovered that an overproduction of E. coli bacteria is triggered by the availability of sialic acid, leading to intestinal inflammation. A sialidase inhibitor can prevent excessive E. coli formation and alleviate disease symptoms.
A study published in JAMA Surgery found that women who underwent Roux-en-Y gastric bypass surgery had a faster increase in blood alcohol concentration and reported greater feelings of drunkenness. This alteration in alcohol metabolism increases the risk of developing alcohol use disorders, highlighting the need for public awareness.
A genetic mutation has been identified as the cause of congenital sucrose-isomaltase deficiency (CSID), a disorder that prevents the absorption of sucrose in Inuit people. The study found that CSID is more common in Inuit individuals living in northern Canada and Greenland.
Eosinophilic gastritis is a chronic inflammatory condition characterized by high levels of eosinophils in the blood and gastrointestinal tract. The study found that it involves allergy-associated-immune mechanisms and has a distinct gene expression pattern, paving the way for improved diagnosis and treatment.
Researchers have mapped 500 unknown microorganisms in human intestines and 800 bacteriophages that attack them. This new understanding could lead to more targeted treatments for diseases like type 2 diabetes, asthma, and obesity.
A study found that giving probiotics to infants during the first three months of life can prevent gastrointestinal disorders like colic, acid reflux, and constipation. This approach results in lower healthcare costs for families.
A new type of deadly intestinal lymphoma has been identified in Asian patients, with a novel biomarker and diagnostic test developed to accurately diagnose the disease. The study's findings impact the 2008 WHO classification and offer improved treatment strategies.